| Project/Area Number |
22710112
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Nanomaterials/Nanobioscience
|
|---|
| Research Institution | National Institute of Advanced Industrial Science and Technology |
|---|
Principal Investigator |
NAKAMURA Maki 独立行政法人産業技術総合研究所, ナノチューブ応用研究センター, 産総研特別研究員 (00568925)
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2010: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Keywords | ナノ材料 / 機能性材料 / カーボンナノホーン / 経口投与 / 薬物送達 / 腸疾患治療 / カーボンナノチューブ / DDS |
|---|
| Research Abstract |
Carbon nanotubes are nanometer-sized carbon materials, which are expected to be applicable to drug carriers of drug delivery systems. In mice experiment, orally-administered carbon nanotubes were not absorbed from the gastrointestinal tract, and excreted in feces, suggesting that neither accumulation of orally-administered carbon nanotubes in body nor associated toxicity would be observed. These results indicated that carbon nanotubes could be riskless oral drug carriers in drug therapy of inflammatory bowel diseases.
|
